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1 |  INTRODUCTION
Congenital hearing loss is a frequent birth defect affecting ap-
proximately 3/1000 newborns (Erenberg et al., 1999; Mehl & 
Thomson, 1998; White, 2004). Early detection and interven-
tion is paramount for language development in these children 
(Moeller, 2000; Yoshinaga- Itano et al., 1998). Standardized 
hearing screening of infants have, therefore, been introduced 
in most developed countries. A national screening program 
of infants at 3 days of age was launched in Denmark in 2005 
with a screening density currently exceeding 95% (Linnebjerg 
et al., 2017).
Hearing loss can occur isolated with abnormalities re-
stricted to the inner ear (non- syndromic hearing loss) or can be 
seen as part of a syndrome with multiple abnormalities (syn-
dromic hearing loss). Non- syndromic hearing loss (NSHL) 
accounts for approximately 70% of hereditary hearing loss 
and multiple modes of inheritance have been reported, of 
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Abstract
Background: CABP2- related non- syndromic hearing loss have only been reported in 
a few families worldwide (Iran, Turkey, Pakistan and Italy). The hearing loss was in 
these cases described as prelingual, symmetrical, and moderate to severe.
Methods: Following DNA isolation, exome sequencing was performed in 123 genes 
related to non- syndromic hearing loss. Variant verification and carrier testing were 
performed by direct sequencing.
Results: We report the first Northern European individual with CABP2- related 
hearing loss: an 8- year- old Danish Caucasian boy with non- syndromic, prelingual, 
and sensorineural hearing loss, who is homozygous for the splice site variant CABP2: 
c. 637+1G>T previously found in three Iranian families and in one Pakistani family. 
Both parents are of Danish Caucasian origin with no known history of consanguinity. 
This is in contrast to the four reported Middle Eastern families, who all were 
consanguineous. However, loss of heterozygosity in a 3.2 Mb area on chromosome 
11 including CABP2 was observed, suggesting a common parental ancestor.
Conclusion: We report the first case of CABP2- related autosomal recessive hearing 
loss in Northern Europe. The index is of Danish Caucasian origin and found to be 
homozygous for the splice site variant c.637+1G>T.
K E Y W O R D S
autosomal recessive, CABP2, hearing loss
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which, autosomal recessive being the most prevalent (Smith 
et al., 2005). To date 76 genes have been reported in rela-
tion to autosomal recessive non- syndromic hearing loss 
(ARNSHL) (Hereditary Hearing Loss Homepage accessed 4 
February 2020) including CABP2 (OMIN 607314).
CABP2 is part of a family of Ca2+- binding proteins 
(CABPs) with high similarity to calmodulin. Ca2+- binding 
protein 2 is expressed in the cochlea and modulate presyn-
aptic influx of calcium in the inner hair cells thus affecting 
further transmission of auditory information to the brain via 
voltage gated Ca- channels (Cui et al., 2007). Ca2+- binding 
protein 2 (CABP2) is found to regulate hearing sensitivity in 
inner hair cells and is required for the normal function of the 
peripheral auditory system (Yang et al., 2018).
ARNSHL as a result of pathogenic variants in CABP2 has 
previously been reported in four Iranian families (Koohiyan 
et al., 2019; Schrauwen et al., 2012), one Turkish fam-
ily (Bademci et al., 2016), one Italian family (Picher et al., 
2017), and one Pakistani family (Richard et al., 2019) (Table 
1). The hearing loss in these cases was described as prelin-
gual, symmetrical, moderate- severe, and more pronounced 
in the mid frequencies resulting in U- shape audiogram. So 
far, four different pathogenic variants in CABP2 have been 
identified.
2 |  MATERIALS AND METHODS
2.1 | Clinical report
We present the molecular genetic findings of an 8- year- old boy 
with prelingual, sensorineural, moderate, and symmetrical 
hearing loss. The child was born in 2010 from Danish 
Caucasian non- consanguineous parents following a normal 
pregnancy (gestation week 42). The birth was reported to be 
fast and the boy was born within minutes at home, initially 
blue and quiet but had a quick recovery. Birthweight was 
3400 g and length was 51 cm. No treatment for jaundice was 
needed and blood tests showed no signs of CMV infection.
Bilateral hearing loss was detected when the patient was 
3 days old by the national standardized hearing screening. As 
a young child, he had numerous bilateral otitis media infec-
tions and underwent eardrum tubulation four times. At the 
age of seven, he was referred from a private practitioner to 
hearing loss treatment with hearing aids. The patient's hear-
ing loss was symmetrical, moderate, and more pronounced 
in the mid frequencies resulting in a U- shaped audiogram 
(Figure 1).
At the age of eight, the boy was referred to genetic coun-
seling. Elaborate family history on the patient's mother's side 
revealed other family members with non- syndromic hearing 
loss and the need for hearing aids in adolescence and early 
adulthood (Figure 2). The mother of the patient also had im-
paired hearing, but with no need for hearing aids at the age 
of 35. Based on the pedigree, an autosomal dominant inheri-
tance initially seemed most likely.
2.2 | Editorial policies and ethical 
considerations
Oral informed consent was obtained by the patient's father at 
consultation.
2.3 | Molecular evaluation, verification, and 
carrier testing
DNA was isolated according to standard procedures from 
blood leukocytes. Exome sequencing was performed using 
SureSelect XT HS exome kit (Agilent Technologies Inc.) 
and the library was sequenced on NextSeq (Illumina Inc.). 
Inspection and visualization of variants in the 123 genes related 
to non- syndromic hearing loss were performed manually 
using VarSeq version 1.4.4 (Golden Helix Inc.). Subsequent 
variant verification and carrier testing of the patient's 
father were performed by direct sequencing using forward 
primer GAGCTACGGGACGCCTTC and reverse primer 







Iran (Schrauwen et al.,2012)
1239 c.490- 1G>T; c.490- 1G>T Turkey (Bademci et al., 
2016)
— c.466G>T; c.466G>T Italy (Picher et al., 2017)
— c.311G>A; c.311G>A Iran (Koohiyan et al., 2019)
DEM4545 c.637+1C>T; c.637+1G>T Pakistan (Richard et al., 
2019)
NSHL57 c.637+1C>T; c.637+1G>T Denmark (this case)
T A B L E  1  Overview of pathogenic 
variants in CAPB2 reported to date
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F I G U R E  1  Audiogram of index. 
Hearing level in dB on the Y- axis and 
frequency in hertz on the X- axis. Red O: Air 
conduction, right ear, unmasked. Blue X: 
Air conduction, left ear, unmasked. Red <: 
Bone conduction, right ear, unmasked. Blue 
>: Bone conduction, left ear, unmasked. 
Red [: Bone conduction, right ear, masked. 
Blue]: Bone conduction. SRT: Speech 
Reception Threshold. DS: Discrimination 
score
F I G U R E  2  Family pedigree. The arrow represents the index patient. Black shading indicates homozygosity for CABP2 c. 637+1G>T and 
halved black shading indicates heterozygosity. The vertical line represents family history of adolescence/adult onset of non- syndromic hearing loss
F I G U R E  3  Direct sequencing results of the (NM 016366.3) CABP2 c.637+1G>T mutation in the index patient, carrier (father) and control
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TGCTGTGCGGTTTCTTATCTG. Pathogenic variants were 
submitted to the central variant database ClinVar.
3 | RESULTS
The patient was found homozygous for the known splice site 
variant CABP2 (NM_016366.2), c.637+1G>T (Figure  3). 
No other causative variants were identified in the other se-
quenced genes. The homozygous CABP2 mutation has previ-
ously been seen in three Iranian families and in one Pakistani 
family (Richard et al., 2019; Schrauwen et al., 2012). 
Functional studies have shown that this splice site mutation 
leads to complete skipping of exon 6, expected to cause a 
frameshift thus resulting in a premature truncation of the pro-
tein (Schrauwen et al., 2012).
The hearing loss in our index and in the abovementioned 
families, are inherited in an autosomal recessive manner. 
Only carrier testing of the patient's father was possible, where 
heterozygosity of the mutation was confirmed (Figure 3). The 
patient's mother and the remaining family members suffering 
from hearing loss on her side of the family remain genetically 
unresolved.
In this family, no history of consanguinity was re-
ported, however, a 3.2  Mb area with loss of heterozygos-
ity was identified on chromosome 11 involving CABP2 
(Chr11:64577620- 67817743 (GRCh37)), suggesting a com-
mon parental ancestor.
4 |  DISCUSSION
Homozygosity for CABP2: c. 637+1G>T was shown to be 
the cause of non- syndromic, autosomal recessive hearing 
loss in this Danish Caucasian patient. To our knowledge, 
CABP2- related hearing loss has only previously been 
reported worldwide in seven unrelated families (Table 1), 
thus, making our patient the first Northern European with 
CABP2- related hearing loss. Furthermore, our index is the 
first European hearing loss patient with homozygosity for 
the CABP2 c.637+1G>T mutation, making an accurate 
estimate of carrier frequency of pathogenic variants in 
CABP2 in Northern Europe and in Denmark difficult. 
According to the Genomic Aggregation Database 
(GnomAD), the allelic frequency of this mutation in non- 
Finnish Europeans is approximately 0.001 and 0.003 
in Finnish Europeans (Lek et al., 2016) indicating that 
several cases of undiagnosed CABP2- related hearing loss 
due to homozygosity for this mutation exist in European 
populations.
Consanguinity was reported in six of the seven previ-
ously reported families with CABP2- related hearing loss. 
Family relations in the Turkish family were not described 
(Bademci et al., 2016). In the current family, no known his-
tory of consanguinity was reported. However, analysis of 
the exome data from our index, showed loss of heterozygos-
ity in a 3.2  Mb area on chromosome 11 involving CABP2 
(Chr11:64577620- 67817743 (GRCh37)), suggesting a com-
mon parental ancestor.
Family history revealed additional cases of hearing im-
pairment on the patient's mother's side of the family, includ-
ing his mother, who had a slight hearing loss. The patient's 
grandmother and uncle on his mother's side were both treated 
with hearing aids in their forties and teenage years, respec-
tively. These affected relatives remain, however, genetically 
unresolved.
The protein encoded by CAPB2, Ca2+- binding protein 
2, has previously been shown also to be present in the ret-
ina (Haeseleer et al., 2000). Ophthalmological investigations 
have, therefore, been performed on individuals with CABP2- 
related hearing loss revealing no eye pathology (Schrauwen 
et al., 2012). To date no additional clinical manifestations 
have been reported, although ectomorphic and marfanoid 
features have been suspected (Schrauwen et al., 2012). 
None of these distinctive features were obvious in the index 
with the proviso, that he was only 8 years old at the time of 
consultation.
5 |  CONCLUSION
To the best of our knowledge, this is the first report of a 
patient with CABP2- related autosomal recessive hearing 
loss in Northern Europe and the second in Europe. The 
index is of Danish Caucasian origin and found to be 
homozygous for the splice site mutation c.637+1G>T. This 
specific mutation has only previously been reported in three 
Iranian and one Pakistani family all with a family history 
of consanguinity. In this family no history of consanguinity 
was noticed, however, loss of heterozygosity in a 3.2 Mb 
area including CABP2 on chromosome 11 suggested a 
common parental ancestor.
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